Impact ofMTHFRgene C677T polymorphism onBcl-2gene methylation and protein expression in colorectal cancer
- 6 December 2010
- journal article
- Published by Informa UK Limited in Scandinavian Journal of Gastroenterology
- Vol. 46 (4), 436-445
- https://doi.org/10.3109/00365521.2010.537682
Abstract
To investigate the impact of MTHFR C677T polymorphism on Bcl-2 gene promoter CpG island (CGI) methylation and Bcl-2 protein expression. MTHFR polymorphisms of 86 sporadic colorectal cancer (CRC) patients and 100 healthy volunteers were analyzed by PCR-based restriction fragment length polymorphism, and Bcl-2 promoter CGI methylation in 86 CRC tissues and 86 paired nonneoplastic adjacent tissues was determined by methylation-specific PCR. Bcl-2 oncoprotein expression in 70 CRC tissues and paired nonneoplastic adjacent tissues was detected by immunohistochemistry. The frequency of MTHFR 677 T allele and combined variant genotypes (677CT + TT) in CRC patients was significantly higher than that in healthy controls (p = 0.023 and p = 0.035, respectively), and there is a significant association between 677TT or 677(CT + TT) genotypes and CRC (OR = 2.534, p = 0.045 and OR = 1.888, p = 0.035, respectively). The frequency of methylated Bcl-2 promoter CGI in tumor tissues was significantly lower than that in nonneoplastic adjacent tissues (p = 0.014). The frequency of methylated Bcl-2 promoter CGI in CRC tissues of the individuals with CC genotype was significantly higher than that of those with CT/TT genotypes (p = 0.018), there was significant distribution difference of C and T alleles between individuals with methylated and unmethylated Bcl-2 promoter CGI in colorectal cancer tissues (p = 0.023). Bcl-2 promoter hypomethylation was significantly correlated with Bcl-2 oncoprotein expression in colorectal cancer tissues (r = 0.558, p < 0.001). Bcl-2 promoter is hypomethylated in colorectal cancer tissue, and there is a significant correlation between MTHFR 677 TT or CT/TT genotypes and CRC or Bcl-2 promoter CGI methylation/oncoprotein expression in CRC.Keywords
This publication has 40 references indexed in Scilit:
- Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluationJournal of Ovarian Research, 2009
- Bcl-2 Modulation to Activate Apoptosis in Prostate CancerMolecular Cancer Research, 2009
- SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancerLaboratory Investigation, 2009
- Epstein-Barr Virus Latency in B Cells Leads to Epigenetic Repression and CpG Methylation of the Tumour Suppressor Gene BimPLoS Pathogens, 2009
- Quantitative evaluation of DNA methylation by optimization of a differential-high resolution melt analysis protocolNucleic Acids Research, 2009
- The methylenetetrahydrofolate reductase C677T mutation induces cell‐specific changes in genomic DNA methylation and uracil misincorporation: A possible molecular basis for the site‐specific cancer risk modificationInternational Journal of Cancer, 2009
- The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancerActa Oncologica, 2009
- Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and TherapyJournal of Clinical Oncology, 2008
- Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAXBritish Journal of Cancer, 2007
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995